Entity Details

Primary name AMPD2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ01433
EntryNameAMPD2_HUMAN
FullNameAMP deaminase 2
TaxID9606
Evidenceevidence at protein level
Length879
SequenceStatuscomplete
DateCreated1993-07-01
DateModified2021-06-02

Ontological Relatives

GenesAMPD2

GO terms

Show/Hide Table
GOName
GO:0003876 AMP deaminase activity
GO:0005829 cytosol
GO:0006188 IMP biosynthetic process
GO:0032264 IMP salvage
GO:0042802 identical protein binding
GO:0043101 purine-containing compound salvage
GO:0046033 AMP metabolic process
GO:0046872 metal ion binding
GO:0052652 cyclic purine nucleotide metabolic process
GO:0097009 energy homeostasis

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR001365 Adenosine/AMP deaminase domainDomainDomain
IPR006329 AMP deaminaseFamilyFamily
IPR006650 Adenosine/AMP deaminase active siteSiteActive site
IPR029749 AMP deaminase 2FamilyFamily
IPR032466 Metal-dependent hydrolaseFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615809 OMIMPontocerebellar hypoplasia 9 (PCH9)A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum, evident upon brain imaging. PCH9 features include severely delayed psychomotor development, progressive microcephaly, spasticity, seizures, and brain abnormalities, including brain atrophy, thin corpus callosum, and delayed myelination. The disease is caused by variants affecting the gene represented in this entry.
615686 OMIMSpastic paraplegia 63, autosomal recessive (SPG63)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. The disease is caused by variants affecting the gene represented in this entry.